Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07148063

Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy

Association of Preoperative Inflammatory Biomarkers With Postoperative Nausea and Vomiting in Children Undergoing Orchiopexy

Status
Recruiting
Phase
Study type
Observational
Enrollment
170 (estimated)
Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital · Other Government
Sex
All
Age
1 Year – 8 Years
Healthy volunteers
Not accepted

Summary

Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators. This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of Preoperative Inflammatory BiomarkersBlood samples will be collected preoperatively to measure inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index, monocyte-to-lymphocyte ratio (MLR), and systemic inflammation response index. These values will be analysed in relation to the incidence of postoperative nausea and vomiting within the first 6 hours after pediatric orchiopexy. No experimental drug or device will be administered as part of the study; all procedures will be conducted within the scope of standard perioperative care.

Timeline

Start date
2025-09-08
Primary completion
2026-03-13
Completion
2026-03-27
First posted
2025-08-29
Last updated
2025-09-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07148063. Inclusion in this directory is not an endorsement.